Eating disorders in obese individuals – a psychiatric or internal medicine issue?

Česká verzia

Authors: E. Kravarová; Š. Slabá; Š. Svačina
Authors place of work: III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MU Dr. Štěpán Svačina, DrSc., MBA
Published in the journal: Vnitř Lék 2010; 56(10): 1093-1095
Category: Obesity 2010

Summary

Many relations are connecting obesity and eating disorders – one disease is often modifying the other. Anorexia Nervosa and Bulimia Nervosa are mostly treated by psychiatrists. Internal medicine specialists are mostly involved only in complications (e. g. malnutrition, ion disorders). Obesity is mostly treated only by internists. Psychiatrists are only involved in some depressive patients. Obese patients with eating disorders are mostly not sent to psychiatric diagnostics. In this article an overview of eating disorder symptoms and classification is given – binge eating disorder, night eating syndrome and grazing. These symptoms are defined and possibilities of diagnosis and treatment are described.

Key words:
eating disorders – obesity – binge eating – night eating – grazing

Zdroje

1. Krch FD et al. Poruchy příjmu potravy. Praha: Grada Publishing 2005.

2. Souček M. Metabolický syndrom. Vnitř Lék 2009; 55: 618– 621.

3. Svačina Š. Léčba obezity u metabolického syndromu. Vnitř Lék 2009; 55: 622– 625.

4. Mezinárodní klasifikace nemocí. Duševní poruchy a poruchy chování. Praha: Psychiatrické centrum 2000.

5. Allison KC, Wadden TA, Sarwer DB et al. Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Obesity (Silver Spring) 2006; 14 (Suppl 2): 77S– 82S.

6. Ricca V, Mannucci E, Moretti S et al. Screening for binge eating disorder in obese outpatients. Compr Psychiatry 2000; 41: 111– 115.

7. Sarwer DB, Wadden TA, Fabricatore AN. Psychosocial and behavioral aspects of bariatric surgery. Obes Res 2005; 13: 639– 648.

8. Mussell MP, Mitchell JE, de Zwaan M et al. Clinical characteristics associated with binge eating in obese females: a descriptive study. Int J Obes Relat Metab Disord 1996; 20: 324– 331.

9. Wheeler K, Greiner P, Boulton M. Exploring alexithymia, depression, and binge eating in self‑ reported eating disorders in women. Perspect Psychiatr Care 2005; 41: 114– 123.

10. Grissett NI, Fitzgibbon ML. The clinical significance of binge eating in an obese population: support for bed and questions regarding its criteria. Addict Behav 1996; 21: 57– 66.

11. Kolotkin RL, Westman EC, Østbye T et al. Does binge eating disorder impact weight‑related quality of life? Obes Res 2004; 12: 999– 1005.

12. Stunkard AJ, Allison KC, Geliebter A et al. Development of criteria for a diagnosis: lessons from the night eating syndrome. Compr Psychiatry 2009; 50: 391– 399.

13. Stunkard AJ, Allison K, Lundgren J. Issues for DSM‑ V: night eating syndrome. Am J Psychiatry 2008; 165: 424.

14. Calugi S, Dalle Grave R, Marchesini G. Night eating syndrome in class II– III obesity: metabolic and psychopathological features. Int J Obes (Lond) 2009; 33: 899– 904.

15. Howell MJ, Schenck CH. Treatment of nocturnal eating disorders. Curr Treat Options Neurol 2009; 11: 333– 339.

16. Saunders R. “Grazing”: a high‑risk behavior. Obes Surg 2004; 14: 98– 102.

17. Colles SL, Dixon JB, O’Brien PE. Grazing and loss of control related to eating: two high‑risk factors following bariatric surgery. Obesity (Silver Spring) 2008; 16: 615– 622.

18. Fried M. Bariatrická chirurgie a ledviny. Vnitř Lék 2008; 54: 468– 471.

19. Wilfley DE, Crow SJ, Hudson JI et al. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo‑ controlled double‑blind study. Am J Psychiatry 2008; 165: 51– 58.

20. Leombruni P, Lavagnino L, Fassino S. Treatment of obese patients with binge eating disorder using topiramate: a review. Neuropsychiatr Dis Treat 2009; 5: 385– 392.

21. Guerdjikova AI, McElroy SL, Welge JA et al. Lamotrigine in the treatment of binge- eating disorder with obesity: a randomized, placebo- controlled monotherapy trial. Int Clin Psychopharmacol 2009; 24: 150– 158.

22. Leombruni P, Lavagnino L, Gastaldi F et al. Duloxetine in obese binge eater outpatients: preliminary results from a 12‑week open trial. Hum Psychopharmacol 2009; 24: 483– 488.